August 2017

NCI Standard Funding Opportunity Announcements

Current and Recent Program Announcements  |  Current and Recent Requests for Applications
Current and Recent NCI and Trans-NIH Initiatives | Requests for Proposals  |  Standard Due Dates


Open All Ranks Non-federal Clinical Trials

The Gateway for Cancer Research
Research Grants

 
Gateway focuses on transformational science via effective clinical trials - when basic science translates into human testing and clinical practice.
Due Dates: Rolling requests for funding conducted in two stages: a Letter of Intent (LOI) and if invited, a full application. Applicants must submit via Gateway's Grant Management System  
Amount & Project Period: Funding is variable and duration is 1 to 3 years
Eligibility: All Ranks
Contact: Gateway Contacts are: Jerian Dixon-Evans, Research Grants Specialist  Jerian.Dixon-Evans@gatewaycr.org (847) 342-7361 and Domarina Oshana, Ph.D., Director of Research and Grants Domarina.Oshana@gatewaycr.org (847) 342-7443
Link: Grant Application Process


Ongoing All Ranks Federal See BAA

Army Research Office Broad Agency Announcement (BAA)
Basic and Applied Scientific Research
W911NF-17-S-0002 01
April 2017 - 31 March 2022

The purpose of this BAA is to solicit research proposals in the engineering, physical, life, and information sciences for submission to the Army Research Office (ARO) for consideration for possible funding. Whitepapers and proposals will be evaluated only if they are for fundamental scientific study and experimentation directed toward advancing the scientific state of the art or increasing basic knowledge and understanding. 
Due Dates: Open until Mar. 31, 2022
Proposers are to submit white papers prior to submission of a complete proposal. Based on assessment of white papers, feedback will be provided to encourage or discourage submission of full proposals.
Amount & Project Period: No specific dollars have been reserved - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: W911NF-17-S-0002


Ongoing Postdocs/Junior Faculty Non-federal Pediatric Brain Tumors

A Kids' Brain Tumor Cure Foundation (aka The PLGA Foundation)
Research Grants

Proposals related to basic and translational projects that can advance understanding of the underlying biology of the development and treatment of pediatric low grade glioma brain tumor (PLGA) tumors will be considered.
Due Dates: Letters of Intent are accepted on an ongoing basis, and are reviewed by an expert panel. Based on this feedback, selected applicants will be invited to submit a full proposal
Amount & Project Period: Funding is based on size, complexity, and potential impact of project, and can be awarded over a one-, two-, or three-year period.
Eligibility: Investigators in the early years of their careers are encouraged to apply.  
Contact: Office of Sponsored Research (x6804)
Link: Apply for an AKBTC Sponsored Grant


July 25 (LOI) All Ranks Federal PCORI

Patient Centered Outcomes Research Institute
Cycle 2 2017 Funding Announcements

PCORI's Online System will open for Cycle 2 2017 PCORI Funding Announcements (PFA) on Friday, June 23, 2017.  The opportunities are:
1.    Pragmatic Clinical Studies to Evaluate Patient-Centered Outcomes - Cycle 2 2017
2.    Limited PCORI Funding Announcement: Dissemination and Implementation of PCORI-Funded Patient-Centered Outcomes Research Results and Products in Real-World Settings - Cycle 2 2017
3. Symptom Management for Patients with Advanced Illness - Cycle 2 2017
Due Dates: Jul. 25 (Letter of Intent)
Invited Applications:  Oct. 23 (OSR) Ι Oct. 25 (Sponsor)
Amount & Project Period: See specific announcement
Eligibility: All Ranks, unless otherwise specified in announcement   
Contact: Office of Sponsored Research (x6804)
Link: Cycle 2 2017 Funding Announcements


July 27
(Pre-Application)		 See Below Federal Prostate

Congressionally Directed Medical Research Programs
Prostate Cancer Research Program (PCRP)
Due Dates: Jul. 27 (Pre-application)
Use eBRAP (for pre-application submissions)
Applications Due: Aug. 08 (OSR) Ι Aug. 10 (Sponsor)
Note:  Confidential letters of recommendation are due August 15th
Contact: Office of Sponsored Research (x6804)
Primary Link: PCRP Program Announcements

 

Early Investigator Research Award
W81XWH-17-PCRP-EIRA

This award is intended to support research that demonstrates the potential to have a major impact on an area of paramount importance in prostate cancer. It is the responsibility of the PI to clearly and explicitly describe the potential impact of the proposed study on prostate cancer and to convey its level of significance.
Amount & Project Period: $200,000 (Direct Costs) - 2 years
Eligibility: Postdoctoral PI must:
Have successfully defended a doctoral thesis or possess an M.D. degree (or equiv.) by March 31, 2018;
Be involved in an accredited postdoctoral training or medical residency program; and
Have 3 years or less of postdoctoral research experience (excluding clinical residency or clinical fellowship training) by March 31, 2018.
PA Link: W81XWH-17-PCRP-EIRA
 

Physician Research Award
W81XWH-17-PCRP-PRA

This Award supports a mentored research experience to prepare physicians with clinical duties and/or responsibilities for productive careers in prostate cancer research. The mentored physician is considered the Principal Investigator (PI) of the application.
Amount & Project Period: $520,000 (Direct Costs) - 4 years
Eligibility: PI must be a physician w/clinical duties and/or responsibilities and, at application submission deadline, is either:
In last year of an accredited graduate medical education program, either as a resident or fellow, or
w/in 3 years of having initiated first appointment as an Instructor, Asst. Professor, or equiv.
(Organization is required to provide at least 40% protection time for prostate cancer research, which can include effort dedicated to other prostate cancer research projects)
PA Link: W81XWH-17-PCRP-PRA



July 27 (LOI) All Ranks Federal Lung

Congressionally Directed Medical Research Programs
Lung Cancer Research Program (LCRP)
Concept Award
W81XWH-17-LCRP-CA

This mechanism supports the exploration of a highly innovative new concept or untested theory that addresses an important problem relevant to lung cancer.  Applications must describe how the new idea will enhance the existing knowledge of lung cancer or develop an innovative and novel course of investigation.
Due Dates: Jul. 27 (Letter of Intent)
Applications Due:  Aug. 08 (OSR) Ι Aug 10 (Sponsor)
Amount & Project Period: $100,000 (Direct Costs) - 1 year
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Links: Primary Link Ι W81XWH-17-LCRP-CA Ι Pre-application Site
Society for Translational Oncology

NEW
July 31 Postdocs/Junior Faculty Non-federal Translational Oncology Forum

Society for Translational Oncology
2017 Society for Translational Oncology Fellows' Forum (STOFF) 

The STOFF is a 3-day intensive forum that brings together fellows and junior faculty from the leading medical, surgical, and radiation oncology subspecialty fellowships to educate rising stars in translational cancer research.  The 2017 forum will be held October 12-15 at The Lansdowne in Leesburg, Virginia.
Due Dates: Jul. 31 (Sponsor) Notification of awards:  August 30th
Amount & Project Period: For fellows currently enrolled in an accredited U.S. training program, the award covers expenses for tuition, course materials, lodging, airfare, ground transportation and meals. Junior faculty will be responsible for lodging, airfare, and ground transportation
Eligibility: Applicants must currently be enrolled in an accredited hematology/oncology or subspecialty training program
or
Be junior faculty within 5 years of training completion with a demonstrated commitment to translational cancer research.
Contact: For questions send email to STOFF@sto-online.org
Links: Overview | Application Information


NEW
July 31 (LOI) All Ranks Non-federal Blood Cancers

Leukemia & Lymphoma Society
New Idea Award

This is a grant program designed to identify novel research strategies with a potential for high impact on blood cancer.  It specifically supports the initial exploration of untested but potentially transformative ideas that challenge knowledge of blood cancer or the manner in which diagnosis or treatment is approached.
Due Dates: Jul. 31 (Letter of Intent)
Invited Applications:  Nov. 28 (OSR) Ι Nov. 30 (Sponsor)
Amount & Project Period: $75,000 - 1 year
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)   
Links: New Idea Award Ι FLUXX (Submission Site)

American Urological Association


NEW
July 31 All Ranks Non-federal Urological

American Urological Association
Data Grants

The purpose is to support studies that address key knowledge gaps and emerging research questions related to urological care delivery, workforce development and health policy.  AUA is particularly interested in supporting population-based, data-driven, specialty generalizable studies using electronic health records, data maintained by the AUA or other data sources already available to investigators.
Due Dates: July 31 (Letter of Intent)
Invited Applications:  Oct. 12 (OSR) Ι Oct. 16 (Sponsor)
Amount & Project Period: $25,000 - 1 year
Eligibility: All AUA members are eligible and encouraged to apply.
Contact: Office of Sponsored Research (x6804)
Link: AUA Data Grants




NEW
August 01 All Faculty Ranks Non-federal Immunotherapy-Melanoma

American Cancer Society and Melanoma Research Alliance
Understanding, Preventing, and Managing Immunotherapy-related Adverse Events (irAEs) Associated with Checkpoint Inhibition for Melanoma and Other Cancers  
Multi-disciplinary Team Award

This initiative of the American Cancer Society and the Melanoma Research Alliance will facilitate research focused on prevention, risk, early detection, and management of short- and long-term immune-related adverse events (irAEs) associated with FDA-approved or late-stage development checkpoint cancer immunotherapies for melanoma and other cancers.
Due Dates: Aug. 01 (Letter of Intent)
Application Due:  Oct. 27 (OSR) Oct.31 (Sponsor)
Paper application copy due Nov. 01 (Sponsor)
Amount & Project Period: $1,000,000 (Total) - 3 years
Eligibility: Teams must include laboratory and clinical investigators from various disciplines. These investigators should be both senior and junior investigators focused collectively on a high priority area regarding immune related adverse events (irAEs). Each team must consist of at least three members: Lead PI, at least one Team Principal and one Team Investigator.
The Lead PI, Team Principals and Team Investigators must hold a doctorate degree (M.D., Ph.D., or equivalent), be independent and have a full-time faculty position or equiv.
Contact: Office of Sponsored Research (x6804)
Links: Application Policies and Instructions
proposalCENTRAL (submission site)


August 01 All Ranks Non-Federal Breast

Florida Breast Cancer Foundation
Scientific Grants

The Foundation is offering scientific grants for Pilot Program research projects.  Preference will be given to research applications that reflect a collaborative and integrated multidisciplinary approach.  Innovative projects can be in the areas of: basic, clinical, and translational breast cancer research and involve epidemiological studies of breast cancer, research on possible links between breast cancer and the environment, and Psycho-immunological, research as examples.
Due Dates: Jul. 28 (OSR) Ι Aug. 01  (Sponsor)
Amount & Project Period: $100,000 - 1 year
Eligibility: All Ranks.  However, priority is given to new investigators.  New investigators are considered to be in the first three years of a tenure-track position, or an equivalent independent research appointment.
Contact: Office of Sponsored Research (x6804)
Link: Request for Scientific Grant Applications
Florida Breast Cancer Foundation


NEW
August 01 See Below Non-Federal Multiple Myeloma

International Myeloma Foundation

Due Dates: Jul. 28 (OSR) Ι Aug. 01 (Sponsor)
Contact: Office of Sponsored Research (x6804)
Primary Link: Apply for an IMF Research Grant
 

Brian D. Novis Junior Research Award

These awards go to researchers doing work in the field of multiple myeloma and related disorders including smoldering myeloma, MGUS (monoclonal gammopathy of undetermined significance) as well as immunoglobulin derived amyloidosis.
Amount & Project Period: $50,000 - 1 year
Eligibility: Completed postdoctoral studies or clinical fellowship by August 1st of application year.
Minimum of 50% effort during award period
Link: Junior Grant Application (PDF)
 

Senior Grant

These awards are designed for projects which represent a different focus, direction, or area of research from those in which the PI is currently funded.  In most cases, these awards will be for pilot projects to obtain sufficient funding for larger applications from NIH or similar larger funding agencies.
Amount & Project Period: $80,000 - 1 year
Eligibility: Established investigators with a track record in myeloma or related disorders;
Ability to provide a completed application with evidence of a meritorious research project
Link: Senior Grant Application (PDF)



August 01 (LOI) See Below Non-Federal General Research Support

American Cancer Society
Clinical Research Professor Awards

These grants provide flexible funding for established investigators in mid-career who have made seminal contributions in areas of cancer control that have changed the direction of clinical, psychosocial, behavioral, health policy or epidemiologic cancer research. It is expected that these investigators will continue to provide leadership in their research area. The award also may be used to support similarly qualified individuals who are dedicated to bringing advances in basic sciences into the clinical arena and to articulating clinical problems for basic research scientists. An American Cancer Society Clinical Research Professor is required to be a spokesperson for the American Cancer Society and for cancer research.
Due Dates: Aug. 01 (Letter of Intent)
Invited Applications:  Oct. 13 (OSR) Ι Oct. 15 (Sponsor)
Amount & Project Period: $400,000 - 5 years
Eligibility: Full professor or equiv.
Must not have held rank of full professor or equiv. for more than 15 years
Contact: Office of Sponsored Research (x6804)
Link: Overview Ι Policies Ι proposalCENTRAL 


August 01 See Below Non-Federal Career Development

American Cancer Society
Audrey Meyer Mars International Fellowship

The purpose is to provide advanced training in clinical oncology at participating cancer centers in the United States to qualified physicians and dentists from other countries, particularly countries where advanced training is not readily available. Moffitt is a participating center.
Due Dates: Jul. 28 (OSR) Ι Aug. 01 (Sponsor)
Paper applications due on Aug. 02
Amount & Project Period: $65,000 - 1 year
Eligibility: Candidate must be  a qualified physician  with a demonstrated an interest in clinical cancer management.
Candidate must be accepted for training by the participating institution and must have fulfilled all requirements of the institution and of the state in which the institution is located. Candidate must be certified by the Education Commission for Foreign Medical Graduates (ECFMG)
Contact: Office of Sponsored Research (x6804)
Link: Overview | Policies | proposalCENTRAL


August 02 - 4:00pm See Below Non-Federal Team Science

Team Science Award

The AACR Team Science Award will recognize an outstanding interdisciplinary research team for its innovative and meritorious science that has advanced or likely will advance our fundamental knowledge of cancer or a team that has applied existing knowledge to advance the detection, diagnosis, prevention, or treatment of cancer.
Due Dates: Aug. 02 (Sponsor)
Amount & Project Period: The team selected to receive the 12th Annual AACR Team Science Award will collectively be awarded a prize of $50,000 and be recognized during the AACR Annual Meeting 2018 in Chicago, Illinois, USA (April 14-18, 2018).
Eligibility: Team is comprised of independent faculty-level researchers providing complementary interdisciplinary expertise, each of whom have made separate substantive and quantifiable contributions to research being recognized.
May be working within same institution or at several institutions; however, if researchers are in same institution, they must have clearly separate funding and research space; Research to be recognized should reflect work towards a specific scientific goal that otherwise would not be realized by any single component of team.
Contact: Questions regarding eligibility of a Team may be directed to AACR's Scientific Achievement Awards office at awards@aacr.org or call (215) 446-7128, prior to submitting a nomination.
Link: proposalCENTRAL (For description, guidelines, and submission of nomination)


NEW
August 04 Established faculty Non-federal Gastric

American Gastroenterological Association R.
AGA-R. Robert & Sally Funderburg Research Award in Gastric Cancer

The objective of this award is to support an established investigator in the field of gastric biology whose research will enhance the fundamental understanding of gastric cancer pathobiology to ultimately prevent or develop a cure for the disease.
Due Dates: Aug. 02 (OSR) Ι Aug. 04  (Sponsor)
Amount & Project Period: $100,000 - 2 years
Eligibility: Candidates must hold a full-time faculty position;
Candidates must be established as an independent investigator in the field of gastric biology;
AGA membership is required at the time of application submission.
Contact: Office of Sponsored Research (x6804)
Link: Information and Process


August 05 All Ranks Non-federal Mesothelioma

The Meso Foundation
Mesothelioma Research Funding

Eligible projects may relate to benchwork, translational or clinical research not presently funded.  Encouraged projects include: Strategies for early detection and prevention of mesothelioma; Definition of targetable differences between normal and transformed mesothelium and development of novel strategies for treatment taking advantage of these targets; Determination of clinical/molecular determinants for prognosis; and Therapeutic intervention, including: immune response targeted therapy; novel chemotherapeutic compounds; and novel radiation or surgical techniques.
Due Dates: Aug. 03 (OSR) Ι Aug. 05 (Sponsor
Amount & Project Period: $100,000 - 2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Links: Overview | proposalCENTRAL


NEW
August 11 (LOI) All Faculty Ranks Non-federal See Research Priorities Below

Florida Department of Health
Florida Biomedical Research Programs

FY 2017-2018 Bankhead-Coley Cancer Research Program

The following mechanisms are available and described in the program announcement: Discovery Science,  Clinical Research and Bridge Awards.  There are seven research priorities described in the program announcement:  Prevention & Treatment, Health Disparities, Screening, Obesity, Treatment-related Morbidities, Technology Transfer Feasibility(TTF), and Investigational New Drug (IND).
Due Dates: Aug. 11 (Letter of Intent)
Full Applications Due:  Sept. 20 (OSR) Ι Sept. 22 (Sponsor)
Amount & Project Period: Discovery Science:  $900,000 (Total) - 3 years
Clinical Research:   $1,500,000 (Total) - 5 years
Bridge:   $100,000 (Total) - 6 months
Eligibility: Must be a full time faculty member by the time the application is submitted; Must be a U.S. citizen or permanent resident
Contact: Office of Sponsored Research (x6804)
Links: FY 2017-2018 Bankhead-Coley Cancer Research Program
FBRP Funding Opportunities


NEW

August 11 (LOI) All Faculty Ranks Non-federal See Research Priorities Below

Florida Department of Health
Florida Biomedical Research Programs

FY 2017-2018 James & Esther King Biomedical  Program

The following mechanisms are available and described in the program announcement: Discovery Science, Clinical Research and Bridge Awards.  There are eight research priorities described in the program announcement:  Prevention & Treatment, Health Disparities, Screening, Tobacco Use, Obesity, Treatment-related Morbidities, Technology Transfer Feasibility(TTF), and Investigational New Drug (IND).
Due Dates: Aug. 11 (Letter of Intent)
Full Applications Due:  Sept. 20 (OSR) Ι Sept. 22 (Sponsor)
Amount & Project Period: Discovery Science:  $900,000 (Total) - 3 years
Clinical Research:  $1,500,000 (Total) - 5 years
Bridge:  $100,000 (Total) - 6 months
Eligibility: Must be a full time faculty member by the time the application is submitted; Must be a U.S. citizen or permanent resident
Contact: Office of Sponsored Research (x6804)
Links: FY 2017-2018 James & Esther King Biomedical Research Program FBRP Funding Opportunities


August 15 All Ranks Non-Federal Gastrointestinal

Hirshberg Foundation for Pancreatic Cancer Research
Seed Grants

The Foundation seeks and supports investigators whose primary intent is to build a strong curriculum in pancreatic cancer research. It is expected that seed grant awards will generate quality abstracts, papers, presentations, as well as new proposals.
Due Dates: Aug. 11 (OSR) Ι Aug. 15 (Sponsor)
Amount & Project Period: Funding is provided on a year-to-year basis in the amount of up to $40,000.  Programs can be extended for one more year upon a competitive renewal/ progress report, which is evaluated by the Advisory Board. 
Eligibility: All Faculty Ranks;
Research scientists and Research Associates w/recommendation from academic faculty supervisor(s); and
Postdocs after two years of completed training in pancreatic cancer research
Contact: Office of Sponsored Research (x6804)
Link: Overview Ι Application



August 15 Postdocs Non-federal Career Development

Damon Runyon Cancer Research Foundation
Fellowship Award

All theoretical and experimental research relevant to the study of cancer and the search for cancer causes, mechanisms, therapies and prevention are encouraged for this fellowship.
Due Dates: Aug. 12 (OSR) Ι Aug. 15 (Sponsor)
Completed applications and USB flash drives must be in sponsor's office by 4:00 pm (ET) on the deadline - NOT postmarked by the due date.
Amount & Project Period: Funding is comprised of a progressive stipend starting at $52,000 and Expense Allowance ($2,000). -  4 years
Note:  Physician-scientists who have completed their residencies and clinical training and are board eligible in the United States will receive Level 2 funding
Eligibility: For degrees conferred between October 15, 2016 and August 15, 2017.
Contact: Office of Sponsored Research (x6071)
Links: Overview Ι Application Guidelines


NEW
August 16 (Pre-Application) Post Docs/Junior Faculty Non-Federal Urological/Career Development

Research Scholar Awards

The purpose is to provide mentored research training awards to early-career investigators, enabling them to ignite their careers and advance urologic research. 
Due Dates: Aug. 16 (Pre-application)
Sept. 11 (OSR) Ι Sept. 13 (Sponsor)
Amount & Project Period: $40,000/yr. - 1 to 2 years
Cost-sharing is required.
For MD (or equiv. degree) applicants, it is required as matching funding ($40,000 per year) to aid in protecting research time and ensuring provision of a strong scientific environment, laboratory equipment, and supplies to conduct the research.
For PhD (or equiv. degree) applicants, cost sharing is required to support salary/stipend, supplies and equipment to conduct the research, or other direct costs to appropriately support the trainee.
Eligibility: Clinical and postdoctoral fellows < 5 years beyond completing a doctorate or residency, or
Early career investigators w/in first 5 years of beginning a faculty position. 
Applicants must commit to no less than one year of performance on award,  and no less than 50% (MD applicants) or 70%  (for PhD applicants) effort on research.
If research to be conducted in U.S., applicants are not required to be U.S. citizens but must have valid Social Security numbers for IRS purposes.
Contact: Office of Sponsored Research (x6804)
Link: Overview | Research Scholar Award


August 20 (LOI) All Faculty Non-Federal Clinical Cancer Research

Rising Tide Foundation
Clinical Cancer Research - Cycle 3

The purpose of the program is to advance studies that deliver results for cancer patients and empower individuals to develop their skills to make a difference for themselves and the greater community.  RTF supports truly innovative, unique, patient-centered research that has the potential to positively impact the lives of cancer patients in near future. Early stages clinical studies and translational research that can demonstrate the potential for quick and meaningful impact are funded. Basic research or phase III/IV trials are not supported.
Due Dates: Aug. 20 (Letter of Intent) - If the proposed project meets Rising Tide's funding criteria, an invitation will be extended for submission of a full grant application for further consideration.
Amount & Project Period: The amount of each award is based on the availability of funds. The duration of the award is up to five years or less.
Eligibility: All Faculty
Contact: Office of Sponsored Research - (x6804)
Link: How to apply Ι Program Guidelines


August 24
(Pre-Application)		 See Below Federal Prostate

Congressionally Directed Medical Research Programs
Prostate Cancer Research Program (PCRP)

Due Dates: Aug. 24 (Pre-application)
Use eBRAP (for pre-application submissions)
Applications Due:  Sept. 05 (OSR) Ι Sept. 07 (Sponsor) 
Contact: Office of Sponsored Research (x6804)
Primary Link: PCRP Program Announcements

Clinical Consortium Award
W81XWH-17-PCRP-CCA

This award mechanism provides the support to develop and enhance collaborations and resources necessary for a network of organizations to rapidly execute Phase II or Phase II-linked Phase I (Phase I/II) prostate cancer clinical trials, including investigations of high-impact, novel therapeutic agents or approaches for the management or treatment of prostate cancer. In accordance with PCRP goals, the conduct of Phase I/II trials incorporating investigations of biomarkers for risk assessment, early detection, prediction of aggressiveness, and/or progression of prostate cancer is particularly encouraged.  Support from this award is directed toward consortium infrastructure needs rather than direct support of the research itself.
Amount & Project Period: Coordinating Center: $3,600,000 (Direct Costs) - 3 years Clinical Research Sites:  $600,000 (Direct Costs) - 3 years Note:  Exercise of options for continued performance for each Clinical Research Site after the first year will be contingent upon meeting performance metrics outlined in program announcement.
Eligibility: PI must be independent investigator at or above Asst. Professor level (or equiv.)
PA Link:  W81XWH-17-PCRP-CCA
 

Prostate Cancer Pathology Resource Network Award
W81XWH-17-PCRP-PCPRNA

 This award mechanism is intended to provide infrastructure support for development and maintenance of a prostate cancer biorepository through a collaborative network across multiple institutions that will facilitate the collection, processing, annotation, storage, and distribution of high-quality human prostate cancer biospecimens.
Amount & Project Period: Combined total direct costs of Initiating PI and all Partnering PIs' awards will not exceed $3.6M direct costs. - 3 Years
Eligibility: PI must be independent investigator at or above Asst. Professor level (or equiv.) with access to appropriate facilities.
PA Link: W81XWH-17-PCRP-PCPRNA
U01 NIH
NCI is a participating Institute

NEW
August 31 (LOI) All Ranks Federal Multiscale Models of Cancer Processes

Predictive Multiscale Models for Biomedical, Biological, Behavioral, Environmental and Clinical Research

The goal of this interagency funding opportunity announcement (FOA) is to support the development of multiscale models to accelerate biological, biomedical, behavioral, environmental and clinical research. NCI is interested in supporting development of predictive multiscale models of cancer processes. These models may be designed to elucidate basic mechanisms underlying cancer initiation and progression and/or to address important translational, clinical or epidemiological questions related to cancer risk, prevention, diagnosis and treatment.
Due Dates: Letter of Intent requested 30 days prior to due date
Sept. 27 (OSR) Ι Sept. 29 (Sponsor)
Amount & Project Period: Limited to below $500,000/yr. (Direct Costs). - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-15-085
Florida Blue Foundation

NEW
August 31 All Faculty Ranks Non-federal Health Disparities

Florida Blue Foundation
Improve Consumer Health

The Improve Consumer Health program focuses on healthy lifestyles to promote better health for families and communities.  There are two funding areas: 
Awareness and preventive projects designed to educate populations in need* about mental and behavioral health;
OR
Projects designed to train and create materials to assist populations in need* to navigate the health care system and take control of their health.

*For the purpose of this program, the term populations in need is defined as Floridians who are underserved, underinsured or low-income.
Due Dates: Aug. 29 (OSR) Ι Aug. 31 (Sponsor)
NOTE:  There will be Application Clarification Conference Calls on July 21st 10:30 a.m. - 11:30 a.m. & July 24th 10:00 a.m. - 11:00 a.m.  To participate, dial toll-free: 1-800-882-3610. The pass code is 2871940#.
Amount & Project Period: $80,000 - $100,000 – 2 or 3 years
Eligibility: All Faculty Ranks
Contact: Office of Sponsored Research (x6804)   
Links: Florida Blue Foundation  Ι Applications


NEW
September 01 See  Below Non-Federal Informatics

PhRMA Foundation - Informatics

The goal of the Informatics program is to promote development and use of novel informatics in an integrative approach toward understanding normal processes of human biology and disease processes.  
Due Dates: Aug. 30 (OSR) Ι Sept. 1 (Sponsor)
Contact: Office of Sponsored Research (x6804)

Post-Doctoral Fellowships

Amount & Project Period: $40,000/yr. (Stipend only) - Funding is for up to two years, but not beyond the third year of the existing post doctorate.
Eligibility: Applicants must 1) hold a Ph.D. in a field of study logically or functionally related to the proposed post-doctoral activities or 2) expect to receive the Ph.D. before activating the award.
All applicants must be U.S. citizens or permanent residents.
Links: Informatics Ι Post-Doctoral Fellowships

Research Starter Grants

Amount & Project Period: $100,000 - 1 year
Eligibility: Those holding tenure track position of assistant professor or research track research assistant professor appointment (i.e., not instructor) 
All applicants must be U.S. citizens or permanent residents.
Links Informatics Ι Research Starter Grants




September 01 All Ranks Non-Federal Clinical Oncology

Hope Foundation
Impact Award

This award is a funding program from the Hope Foundation that encourages novel and innovative SWOG research by supporting early and conceptual stages of such projects. Proposed work should use resources from completed SWOG trials or be directly translatable to future clinical trials in SWOG and the National Clinical Trials Network (NCTN). Studies may involve scientific risk but potentially lead to a breakthrough in a particular area, or to development of novel techniques, agents, methodologies, models, or applications that could have a major impact on cancer research.
Due Dates: Aug. 30 (OSR) Ι Sept. 01 (5:00, pm ET) (Sponsor)
Next Due Date:  March 01, 2018
Amount & Project Period: Up to $250,000 (TOTAL) - 2 years
Eligibility: Any SWOG member investigator eligible for NIH funding is encouraged to submit to this program.
Basic Science applicants are required to partner with a clinician as a Co-PI.
Contact: Office of Sponsored Research (x6804)
Links: Impact Award Ι 2017 RFA
DP1 NIH
NIH Common Fund
September 01 All Ranks Federal Non-Specific

NIH Director's Pioneer Award Program

This program complements NIH's traditional, investigator-initiated grant programs by supporting individual scientists of exceptional creativity who propose pioneering and possibly transforming approaches to addressing major biomedical or behavioral challenges that have the potential to produce an unusually high impact on enhancing health, lengthening life, and reducing illness and disability. To be considered pioneering, the proposed research must reflect substantially different scientific directions from those already being pursued in the investigator's research program or elsewhere.
Due Dates: Aug. 30 (OSR) Ι Sept. 01 (Sponsor)
Amount & Project Period: $700,000/yr. (Direct Costs) - 5 years
Eligibility: All Ranks - Only single PD/PI applications are allowed. Applications with multiple PD(s)/PI(s) will not be accepted.
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-RM-17-005




NEW
September 05 (LOI) All Ranks Non-Federal Translational Research

SU2C Dream Team Translational Research Grant

This initiative will fund a translational cancer research project that will address critical problems in patient care, including prevention strategies for those at risk, and deliver near-term patient benefit through investigation by a multidisciplinary, multi-institutional, collaborative Dream Team of expert investigators.  The ideas may focus on particular organ sites, patient populations (such as pediatrics) or on innovative methods of treatment. 
Due Dates: Sept. 05 (Letter of Intent)
Invited Applications:  Jan. 12 (OSR) Ι Jan. 16, 2018 (Sponsor)
Amount & Project Period: $3,000,000.00 - 3 years
Eligibility: All Faculty Ranks - Multi-investigator, multi-institutional projects are required.
Contact: Office of Sponsored Research (x6804)
Link: Overview| proposalCENTRAL
R01 NCI

NEW
September 06 (LOI) All Ranks Federal Health Disparities

Leveraging Population-based Cancer Registry Data to Study Health Disparities

The goal is to efficiently use the existing cancer registry infrastructure by augmenting data already collected with additional information needed to understand health disparities among people diagnosed with cancer. Specifically, this FOA will support the study of factors influencing observed health disparities within the framework of population-based cancer registries by the inclusion of data not routinely collected by or linked to the registries.
Due Dates: Letter of Intent requested 30 days prior to due date
Oct. 13 (OSR) Ι Oct. 16 (Sponsor)
Additional Due Dates:  Standard dates
Amount & Project Period: Application budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-17-289
Companion FOA: PA-17-288 (R21)


NEW
September 06 See Below Non-Federal Mantle Cell Lymphoma

Lymphoma Research Foundation
2018 Grant Applications

Due Dates: Sept. 01 (OSR) Ι Sept. 06 (Sponsor)
Contact: Office of Sponsored Research (x6804)
Primary Link: Available Grant Opportunities
proposalCENTRAL (Submission Site)
 

Clinical Investigator Career Development Award (CDA)

This program is designed to support physician investigators at the level of advanced fellow or junior faculty member who will contribute to the development of new lymphoma therapies and diagnostic tools.
Amount & Project Period: $225,000 over 3  years
Eligibility: Must have no greater than five years of experience beyond completion of their fellowship or postdoctoral training (the five year limit may be non-sequential in cases of pregnancy or illness).
Link: Guidelines and General Instructions for Application
 

Postdoctoral Fellowship Grant

This award is designed to support investigators at the level of advanced fellow or postdoctoral researcher in laboratory or clinic based research with results and conclusions that must be clearly relevant to the treatment, diagnosis or prevention of Hodgkin and/or non-Hodgkin lymphoma. Areas of research may include, but are not limited to, etiology, immunology, genetics, therapies and transplantation.  
Amount & Project Period: $105,000 over 2  years
Eligibility: Must hold an MD, PhD, or equiv. degree.
MD Applicants must have completed at least two years (24 months) fellowship work at start of award period (March 1, 2018).
All applicants should not have completed more than five years (60 months) of fellowship or postdoc work at start of award period. Individuals holding faculty positions prior to March 1, 2018 are not eligible to apply;
Awarded applicants may move into faculty positions during award period.
Must spend 80% of their time in research during award period.
Link: Guidelines and General Instructions for Application
 

Lymphoma Clinical Research Mentoring Program (LCRMP)

The LCRMP is an education and mentoring program for fellows and junior faculty with a focus in clinical research in the field of non-Hodgkin and Hodgkin lymphoma.
Amount & Project Period: $5,000/yr. - 2 years
Eligibility: Applicant must be a junior faculty member in first four years of a faculty position or trainees at least in the second year of one of the following ACGME accredited sub-specialty fellowship programs: Hematology/Oncology, Hematology, Medical Oncology, Radiation Oncology, or Hematopathology.
Applicants should not be more than four years beyond completion of fellowship or more than twelve years beyond completion of their MD or equivalent degree.
Studies or proposals that are exclusively laboratory based are not appropriate for the LRF LCRMP.  Proposals must involve clinical observation of human subjects and may include study or development of new diagnostic methods, therapies, and/or outcome measurements directed to patients with lymphoma are required.
Link: 2018-2020 Program Overview, Guidelines and Instructions for Application
 

Adolescent/Young Adult (AYA) Lymphoma Correlative Studies

This RFA seeks proposals for correlative clinical/translational studies in adolescent/ young adult (AYA) lymphomas.  Applications may focus on either biomarkers and the biology of AYA lymphomas, or clinical outcomes/survivorship and health services studies which specifically impact the AYA lymphoma population.
Amount & Project Period: $100,000 - 2 years
Eligibility: All Faculty Ranks
Link: Guidelines and General Instructions for Application
 

Mantle Cell Lymphoma (MCL) Therapeutic Studies

This RFA seeks proposals for clinical/translational studies, including correlative studies, in mantle cell lymphoma (MCL). Applications should relate to work in the clinical setting and/or involve primary MCL patient samples. Proposals which are adjunct to an existing research project in MCL are strongly encouraged.
Amount & Project Period: $250,000 - 3 years
Eligibility: All Faculty Ranks
Link: Mantle Cell Lymphoma (MCL) Therapeutic Studies Grant RFP


Updated
September 07 (LOI) See Below Federal Team Science

Concern Foundation
The Conquer Cancer Now Award

Proposals must be hypothesis-driven and centered on cancer genetics, cancer biology, or cancer immunology. Concern will not fund clinical trials, cancer epidemiology, or behavioral studies.
Due Dates: Sept. 07 (Letter of Intent)
Invited Applications:  Dec. 05 (OSR) Ι Dec. 07 (Sponsor)
Amount & Project Period: $120,000 - 2 years
Eligibility: Junior faculty - independent at the start of scientific career and at level of Asst. Professor (or equiv. with explanation)
Contact: Office of Sponsored Research (x6804)
Link: Grant Guidelines Ι proposalCENTRAL (For description, guidelines, and submissions)
DP2 NIH
NIH Common Fund
September 08 Junior Faculty Federal Career Development

NIH Director's New Innovator Award Program

This program supports a small number of early stage investigators of exceptional creativity who propose bold and highly innovative new research approaches that have the potential to produce a major impact on broad, important problems in biomedical and behavioral research.
Due Dates: Sept. 06 (OSR) Ι  Sept. 08 (Sponsor)
Amount & Project Period: $1,500,000 (Direct Costs) - 5 years
Due to multi-year funding reporting requirements, projects must end June 30, 2023.
Eligibility: Applicants must meet definition of an Early Stage Investigator (ESI) at time of application.
Applicants must hold an independent research position as of September 1, 2018.
Applicants may submit or have an R01 (or other equivalent) grant application pending concurrently that does not overlap substantially.
However, if that pending grant is awarded prior to the NIH Director's New Innovator Award, then the applicant is no longer eligible to receive the New Innovator Award.
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-RM-17-006


NEW
September 12 (Pre-Application) Junior Faculty Federal Career Development

Peer Reviewed Cancer Research Program (PRCRP)  
Career Development Award
W81XWH-17-PRCRP-CDA

The PRCRP Career Development Award supports independent, early-career investigators to conduct impactful research with mentorship of an experienced cancer researcher as an opportunity to obtain funding, guidance, and experience necessary for productive, independent careers at the forefront of cancer research. Preliminary data are not required. However, logical reasoning and a sound scientific rationale for the proposed research must be demonstrated.
Due Dates: Sept. 12 (Pre-application)
Full Applications Due:  Sept. 26 (OSR) Ι Sept. 28 (Sponsor)
Amount & Project Period: $360,000 (Direct Costs) - 3 years
Eligibility: Must be independent, early-career researcher or physician-scientist w/in 10 years of completing terminal degree (excl. time in residency or on family medical leave)
Minimum of 30% protected time required for proposed research (more protected time is highly desirable)
Designated Mentor must hold position at or above Associate Professor (or equiv.)
Contact: Office of Sponsored Research (x6804)
Link: W81XWH-17-PRCRP-CDA


NEW
September 12 All Ranks Federal Biomedical Big Data

Joint NSF/NIH Initiative on Quantitative Approaches to Biomedical Big Data (QuBBD)

This program is designed to support research that addresses important application areas at the intersection of the biomedical and data sciences by encouraging inter- and multi-disciplinary collaborations that focus on innovative and transformative approaches to address these challenges.
Due Dates: Sept. 08 (OSR) Ι Sept. 12 (Sponsor)
Amount & Project Period: $200,000 to $300,000/yr.  (Total) - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: 16-573 | Program Page
R01 NCI

September 12 (LOI) All Ranks Federal Health Disparities

U.S. Tobacco Control Policies to Reduce Health Disparities

The purpose of this FOA is to support observational or intervention research focused on reducing health disparities in tobacco use in the U.S.  Specifically, it is intended to stimulate scientific inquiry focused on innovative tobacco control policies.
Due Dates: Sept. 12 (Letter of Intent)
Oct. 09 (OSR) Ι Oct. 11 (Sponsor)          
Additional due dates:  June 13, & October 11, 2018
Amount & Project Period: Application budgets not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: PAR-17-217
Companion FOA: PAR-17-218 (R21)
U01 NIH
NCI is a participating institute

NEW
September 13 (LOI) All Ranks Federal Genomics

Expanding Genome Integrity Assays to Population Studies

The FOA will support development and pilot testing of assays, such as DNA repair capacity or mutation detection, that will facilitate the wider use of genome integrity investigation in epidemiological and population studies.
Due Dates: Sept. 13 (Letter of Intent)
Applications Due:  Oct. 11 (OSR) Ι Oct. 13 (Sponsor)
Amount & Project Period: NCI:  $700,000 - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-ES-17-006



September 13 (Pre-application) All Ranks Federal Lung

Congressionally Directed Medical Research Programs
Lung Cancer Research Program (LCRP)
Career Development Award
W81XWH-17-LCRP-CDA

This mechanism supports early-career, independent investigators to conduct impactful research under the mentorship of an experienced lung cancer researcher as an opportunity to obtain the funding, mentoring, and experience necessary for productive, independent careers at the forefront of lung cancer research. This award is intended to support impactful research projects with an emphasis on discovery.
Due Dates: Sept. 13 (Pre-application)
Full Applications Due:  Sept. 25 (OSR) Ι Sept. 27 (Sponsor)
Amount & Project Period: $250,000 (Direct Costs) - 2 years
Eligibility: Must be an independent investigator at the level of Assistant Professor, Instructor, or equivalent w/in 5 years of first faculty appointment (or equiv.) by application submission;. Must have at least 40% of protected time for lung cancer research;
Must not have received a CDMRP Career Development Award (or equiv.) from any program within the CDMRP;
Must not have received more than $300,000 in total direct costs for previous or concurrent lung cancer research as a PI of one or more Federally or privately funded, non-mentored, peer-reviewed grants.
Contact: Office of Sponsored Research (x6804)
Link: W81XWH-17-LCRP-CDA


NEW
September 15 Junior Faculty Non-Federal Career Development

Alfred P. Sloan Foundation  
Sloan Research Fellows

The Sloan Research Fellowships seek to stimulate fundamental research by early-career scientists and scholars of outstanding promise.  
Due Dates: Sept. 13 (OSR) Ι Sept. 15 (Sponsor)  
Amount & Project Period: $65,000 - 2 years
Eligibility: Must hold a tenure track (or equiv.) position Tenure track faculty positions must include a yearly teaching requirement.
Must hold a Ph.D. (or equiv.) in chemistry, computational or evolutionary molecular biology, computer science, economics, mathematics, neuroscience, physics, or a related field;
Candidates' most recent Ph.D. (or equiv.) must have been awarded on or after September 1, 2011.  Exceptions may apply. 
Contact: Office of Sponsored Research (x6804)
Link: Sloan Research Fellowships




NEW
September 15 PostDocs/Junior Faculty Non-Federal Career Development

The Lung Cancer Foundation of America (LCFA) and the International Association for the Study of Lung Cancer (IASLC)
Lori Monroe Scholarship in Translational Lung Cancer Research

Applications addressing the following research areas will be given priority:
1) Facilitating the collaboration, information-sharing and interaction between basic researchers and clinical investigators with the goal of expediting and translating results of scientific investigation into clinical practice to reduce the burden of lung cancer; or
2) Exploring innovative models of lung cancer care delivery; or
3) Exploring the etiologies of lung cancer in the never smoker population.
Due Dates: Sept. 13 (OSR) Ι Sept. 15 (Sponsor)
Amount & Project Period: $200,000 - 2 years
Eligibility: Applicant must hold a doctoral degree and full-time faculty appointment, and have completed a training fellowship. Award targets junior and midlevel investigators, defined as less than 7 years from first tenure-track appointment, at the assistant or associate professor level.
Applicant's institution must agree to not less than 50% of "protected time" for the applicant to dedicate to research.
Contact: Office of Sponsored Research (x6804)
Link: Grant Opportunity

NEW
September 15 (Abstract) See Specific Award Below Non-federal Career Development

Leukemia & Lymphoma Society
Career Development Program (CDP)

The purpose of the CDP is to enhance the careers of scientists researching blood cancer or normal blood cell biology that has relevance to blood cancer.  LLS offers the opportunity to take part in translational, basic and clinical research, as well as technological and informatics development; however, all approaches must have direct blood cancer relevance.
Due Dates: Jul.  01 - Sept. 01 (Eligibility must be confirmed by 09/01)
Sept. 15 (Abstracts due)
Full Applications Due:  Sept. 29 (OSR) Ι Oct. 03 (Sponsor)
Contact: Office of Sponsored Research (x6804)
Primary Link: Career Development Program
 

Scholar

A Scholar will be a highly qualified investigator w/a capacity for independent, sustained original investigation in hematologic malignancies. Should have obtained substantial research support from a national agency.
Amount & Project Period: $110,000/yr. – 5 years
Eligibility: Must hold independent faculty position w/start date on or after 1/1/2010;
Must have R01-level funding (Substantial, peer-reviewed extending beyond July 1, 2018; must be PI on this funding)
 

Scholar in Clinical Research

A Scholar in Clinical Research is conducting original, independent applied research, often involving early-stage clinical trials that will advance the prevention, diagnosis or treatment of hematologic malignancies.
Amount & Project Period: $125,000/yr. - 5 years
Eligibility: Must hold independent faculty position w/start date on or after 1/1/2008;
Expected to have concomitant support for research from another source or agency;
Must have protected research time in the range of 20%-40%
 

Special Fellow

A Special Fellow is qualified investigator who's completed a minimum of 2 years of postdoctoral research training and is continuing a mentored research position. The intention is to begin to transition to an independent research program.
Amount & Project Period: $67,000/yr. -  2 or 3 years
Eligibility: For a 2 Year Award:  Oral thesis defense on or after 7/1/2013
For a 3 Year Award:  Oral thesis defense on or after 7/1/2014 More details are contained in the Guidelines & Instructions. Sponsor must have R01-level funding (Substantial, peer-reviewed extending beyond July 1, 2018; must be PI on this funding)
 

Fellow

A Fellow is a promising investigator w/less than 2 years of postdoc research training. The intention is to encourage an academic career involving clinical or fundamental research in hematologic malignancies under a research sponsor's direction. Proposal must be directly relevant to hematological malignancies and/or relevant pre-malignant conditions.
Amount & Project Period: $60,000 - 3 years
Eligibility: Oral thesis defense on or after 1/1/2016
Degree must be conferred by Award start date of July 1, 2018
Sponsor must have R01-level funding (Substantial, peer-reviewed extending beyond July 1, 2018; must be PI on this funding)
More details are contained in the Guidelines & Instructions.
R01 NIH

September 15 All Ranks Federal Non-Specific

NIH Director's Transformative Research Awards

This program complements NIH's traditional, investigator-initiated grant programs by supporting individual scientists or groups of scientists proposing groundbreaking, exceptionally innovative, original and/or unconventional research.  Applications supported under this award will reflect ideas substantially different from mainstream concepts.  Requirements for explicitly addressing specific issues, focuses attention on the importance of the problem, the novelty of the hypothesis and/or the proposed methodology, and the magnitude of the potential impact rather than on preliminary data or experimental details, rather than on preliminary data or experimental details.
Due Dates: Sept. 13 (OSR) Ι Sept. 15 (Sponsor)
Amount & Project Period: Application budgets not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-RM-17-007

NEW
September 18 (Pre-application) PostDocs Non-federal Career Development

The Hope Funds for Cancer Research
The Postdoctoral Fellowship

The purpose is to provide fellowships to postdoctoral scientists who propose to work on highly innovative research projects that challenge the traditional paradigms of understanding the causes, mechanisms, progression, disease markers or risk factors of the most difficult-to-treat cancers, including pancreatic, lung, liver, sarcomas, esophageal, brain, gastric, bone and ovarian cancers; and rare leukemias, lymphomas and MDS.
Due Dates: Sept. 18 (Pre-application)
Invited Applications:  Jan. 16 (OSR) Ι Jan. 14, 2018
Amount & Project Period: Stipend: $48,000/yr.01; $50,000/yr.02; and $52,000/yr.03.
A travel grant of $1,500 will be awarded annually to support attendance at  conferences and/or scientific training meetings.
Eligibility: Must have completed 1 or more of the following degrees or its equiv.: MD, PhD, MD/PhD, DDS, DVM. For foreign-trained physicians, equivalency determined on a case-by-case basis. Candidates must conduct proposed research under a sponsor w/a formal appointment at host institution.
Candidates can apply prior to starting or during their postdoctoral appointments provided they have been formally accepted into the lab from which they apply, and current postdoctoral scientists must not have been in their Sponsor's lab for > 2 years as of Sept. 18, 2016.
Contact: Office of Sponsored Research (x6804)
Link: Fellowship Award Eligibility & Application Instructions


&

NIGMS NIH

NEW
September 18 All Ranks Federal Biomedical Mathematics

Joint DMS/NIGMS Initiative to Support Research at the Interface of the Biological and Mathematical Sciences (DMS/NIGMS)

The purpose is to support research in mathematics and statistics on questions in the biological and biomedical sciences. Both agencies recognize the need for promoting research at the interface between the mathematical sciences and the life sciences. This program is designed to encourage new collaborations, as well as to support existing ones.
Due Dates: Sept. 15 (OSR) Ι Sept. 18 (Sponsor)
Amount & Project Period:  $100,000 to $400,000/yr. (Total Costs) - 3 to 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: NSF 17-569


September 19, Noon (Concept Paper) Postdocs/Junior Faculty Non-Federal Career Development

Thrasher Research Fund
Early Career Grants 2017 Fall Cycle

The purpose of this program is to encourage the development of medical research in child health by awarding small grants to new researchers, helping them gain a foothold in this important area. There is no focus on a particular disease.
Due Dates: Sept. 19 (Concept paper)
Invited Applications:  Oct. 04 (OSR) Ι Oct. 06 (Sponsor)
Amount & Project Period: $25,000 (Direct Costs) - 1 to 2 years
Eligibility: Physicians in a residency/fellowship training program or have completed program < 1 year before date of submission of Concept Paper.
Post-docs who received doctoral level degree < 3 years prior date of submission of Concept Paper.
A new investigator who holds an NIH K award or a CTSA is not eligible.
There are no restrictions with regard to citizenship.
Mentors may have only one Thrasher Research Fund Early Career Awardee at a time.
Contact: Office of Sponsored Research (x6804)
Link: Early Career Awards


NEW
September 29 (LOI) All Faculty Ranks Non-federal Blood Cancers/Translational

Leukemia & Lymphoma Society
Translational Research Program (TRP)

This program funds new and innovative research that shows high promise for translating basic biomedical knowledge to clinical application.  The goal of translational research is to reduce the time between laboratory findings and actual treatment.
Due Dates: Sept. 29 (Letter of Intent)
Full Applications:  Nov. 13 (OSR) Ι Nov. 15 (Sponsor)
Amount & Project Period: $200,000/yr. (Total) - 3 years
Eligibility: All Faculty Ranks
Contact: Office of Sponsored Research (x6804)
Links: TRP application process | FLUXX (Submission Site)
September 30 All Ranks Federal Medical Research


Department of Defense - Dept. of the Army - USAMRAA
DoD USAMRMC FY17 Broad Agency Announcement
for Extramural Medical Research
XW1XWH-17-R-BAA1

Projects funded under this BAA must be for basic and applied research to support scientific study and experimentation directed towards advancing the state of the art or increasing knowledge or understanding rather than focusing on development of a specific system or hardware solution.
Due Dates: This Broad Agency Announcement (BAA) is open from October 1, 2016 through September 30, 2017, 11:59 p.m., ET. Pre-proposals are required so that the Government can determine whether a proposed research idea meets USAMRMC's mission and requirements. Pre-proposals may be submitted at any time during the 12-month period.  To submit a full proposal/application, the PI must have received an invitation to submit from a Contracting or Grants Officer.
Amount & Project Period: No  funding limitations specified - 4 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: W81XWH-17-R-BAA1

NEW
October 01 Junior Faculty Non-Federal Career Development

Research Foundation of the American Society of Colon and Rectal Surgeons
Career Development Award

This award focuses on career development and mentorship of the individual rather than solely on the research proposal. The award is intended for the academic investigator demonstrating significant creativity in research relevant to the pathophysiology or management of diseases of the small bowel, colon, rectum, or anus.
Due Dates: Aug. 03 (OSR) Ι Oct. 01 (Sponsor)    
Next Semi-annual Due Date: March 01
Amount & Project Period: $150,000 - 2 years
Eligibility: Must be w/in 5 years of first full-time faculty appointment; Must be a U.S. or Canadian citizen who has completed an approved colorectal surgery training program; and be a member of ASCRS;
Must not currently have or have previously received a career development award
Contact: Office of Sponsored Research (x6804)
Link: Application Instructions



NEW
October 01 PostDocs/New Investigators Non-federal Regenerative Medicine and Cell Therapy

The Sartorius & Science Prize for Regenerative Medicine and Cell Therapy

This prize is focused on basic or translational research that advances regenerative medicine and cell therapy that advances regenerative medicine and cell therapy; for example cell-, gene-, or immunotherapy, tissue engineering, and materials engineering.
Due Dates: Oct. 01 (Sponsor)
Amount & Project Period: Cash prize of $25,000 and a publication of essay in Science Online.  Winners also receive a 5-year membership to the American Association for the Advancement of Science (AAAS).
Eligibility: Entrant must have an advanced degree received on or after January 1, 2007. Candidates for MD/PhD degrees are eligible if either their Ph.D. or final degree was awarded after January 1, 2007;
Entrant must have performed the work described in the essay.
Contact: sartoriusscience@aaas.org
Links: Overview |  How to Enter




NEW
October 01 (LOI) All Faculty Ranks Non-federal Blood Cancers/Translational

Rising Tide Foundation for Cancer Research and Leukemia & Lymphoma Society
RTFCCR/LLS Patient-Focused Prevention

The Rising Tide Foundation for Clinical Cancer Research and the Leukemia & Lymphoma Society offer this competitive grant to advance breakthroughs in prevention for blood cancers.  There are 4 RFP-suggested topics:  Clinical Trials, Biomarker Evaluation, Use of Experimental Systems, and Drug the Undruggable described at the program site. 
Grants must be translational in nature and ideally will have a clinical trial proposed, or could lead to a clinical trial. Applications that are solely laboratory-based without consideration of using patient samples or future clinical testing will not be accepted for review.
Due Dates: Oct. 31 (Letter of Intent)
Full Applications:  Jan. 30 (OSR) Ι Feb. 01, 2018 (Sponsor)
Amount & Project Period: $0.6 - 1.2 M
Eligibility: All Faculty Ranks  
Contact: Office of Sponsored Research (x6804)
Sponsor Contact: Eveline Mumenthaler, Director of RTFCCR (Eveline.mumenthaler@risingtide.ch) or
Lee Greenberger, Chief Scientific Officer of LLS (researchprograms@lls.org)
Links: Academic Grants
Patient-focused Prevention
proposalCENTRAL (Submission Site)


NEW
October 03 All Ranks Federal Mathematical Analysis

National Science Foundation Division of Mathematical Sciences
Analysis Program

Research supported by the Analysis Program provides the theoretical underpinning for the majority of applications of the mathematical sciences to other scientific disciplines.
Due Dates: Sept. 29 (OSR) Ι Oct. 03 (Sponsor)
Amount & Project Period: Amount not stated - 3 to 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: PD 16-1281 | Mathematical Sciences
R01 NCI

NEW
October 05 All Ranks Federal Residential History

Integration of Individual Residential Histories into Cancer Research

The purpose is to support substantive investigation of the role of individual residential histories in cancer etiology and outcomes, and to encourage the development of complex analytical strategies in support of substantive investigation.
Due Dates: Letter of Intent requested 30 days prior to due date
Oct. 03 (OSR) Ι Oct. 05 (Sponsor)
Additional due dates:  Standard dates
Amount & Project Period: Application budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-17-298
Companion Link: PA-17-295 (R21)
R01 NIH
NCI is a participating Institute

NEW
October 05 All Ranks Federal HIV and Aging

Multidisciplinary Studies of HIV/AIDS and Aging  

NCI seeks to foster research studies to help understand how aging in the presence of chronic HIV infection affects the risk, spectrum and biology of cancer (AIDS-defining and non-AIDS-defining cancers).
Due Dates: Oct. 03 (OSR) Ι Oct. 05 (Sponsor)
Additional Due Dates:  Standard dates
Amount & Project Period: Application budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-17-321
Companion FOA: PAR-17-320 (R21)
R01 NIH

NEW
October 11 All Ranks Federal Health Disparities

U.S. Tobacco Control Policies to Reduce Health Disparities

The purpose is to support observational or intervention research focused on reducing health disparities in tobacco use in the U.S. It is intended to stimulate scientific inquiry focused on innovative tobacco control policies.  Applicants may propose projects in which the primary outcome of interest is on reducing tobacco use health disparities in vulnerable populations by utilizing tobacco prevention and control strategies. 
Due Dates: Letter of Intent requested 30 days prior to due date
Oct. 09 (OSR) Ι Oct. 11 (Sponsor)
Additional due dates: June 13, 2018; Oct. 11, 2018; June 13, 2019; Oct. 11, 2019; June 15, 2020
Amount & Project Period: Application budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-17-217
PAR-17-218 (R21)


NEW
October 13 (LOI) All Ranks Non-Federal Bone Marrow Failure and Cancer

Fanconi Anemia Research Fund, Inc.
Research Grants

Supports research focusing on rapid discovery and development of therapies or strategies that treat, control, or cure Fanconi anemia.   There is particular interest in supporting interdisciplinary and translational research efforts including: ·
- Understanding how alteration of the Fanconi anemia genes and their products lead to the clinical manifestations of Fanconi anemia. ·
- Determining causes of bone marrow failure, myelodysplasia and leukemia in individuals with Fanconi anemia, and developing strategies to prevent, treat, and cure these disorders. · - - Defining the pathogenesis of Fanconi anemia-associated cancers, and developing strategies for prevention, early detection, treatment and cure.
Due Dates: Oct. 13 (Letter of Intent)
Invited Applications: Jan. 31 (OSR) Ι Feb. 02, 2018 (Sponsor)
Amount & Project Period: $150,000 - $175,000 over a two year period.
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: Grant Applications
Admin Supplement NIH
NCI is a participating Institute

NEW
October 15 See Below Federal Dietary Supplements

Administrative Supplements for Research on Dietary Supplements

The purpose of these supplements is to support research in which the supplemental funding would investigate the role of dietary supplements and/or their ingredients in health maintenance and disease prevention. 
Due Dates: Oct. 13 (OSR) Ι Oct. 15 (Sponsor)
Addnl. Due Dates:  Jan. 15 and Apr. 15, 2018
Amount & Project Period: Up to $100,000 (Direct Costs) - 1 year (Must be w/in currently approved project period for existing parent award. 
Eligibility: Only active awards w/at least 18 months remaining at time of submission will be considered.  Awards in no-cost extension periods are not allowed to submit an application.  
Contact: Office of Sponsored Research (x6804)
Link: PA-17-307



NEW
October 16 All Faculty Ranks Non-Federal Immunotherapy Melanoma

American Cancer Society & Melanoma Research Alliance
Understanding, Preventing, and Managing Immunotherapy-related Adverse Events (irAEs) Associated with Checkpoint Inhibition for Melanoma and Other Cancers - Pilot Award

This initiative by the American Cancer Society and the Melanoma Research Alliance will award pilot or exploratory projects whose purpose is to test interventions, develop research methodologies and explore novel areas of research leading towards reduction of immune related adverse events (irAEs) and improvement of overall outcomes for cancer patients treated with checkpoint immunotherapy.
Due Dates: Oct. 13 (OSR) Ι Oct. 16 (Sponsor)
Paper application copy due Oct. 17 (Sponsor)
Amount & Project Period: $200,000 (Total) - 2 years
Eligibility: Independent investigators at all stages 
PI must hold a doctorate degree (M.D., Ph.D., or equiv.) and have full-time faculty position or equiv.
Multiple PIs or Co-PIs are not allowed.
Contact: Office of Sponsored Research (x6804)
Link: Pilot Award Policies and Instructions (PDF)
proposalCENTRAL (submission site)


NEW
October 31 All Ranks - See Below Non-Federal Ovarian

Kaleidoscope of Hope (KOH) Ovarian Cancer Research  Foundation
2018 Request for Proposals
General Research Grants & Young Investigator Grants

Proposals in the following areas will be considered:
Early Detection of Ovarian Cancer including precursor cell studies
and
 Treatment of Ovarian Cancer. 
The following areas will not be considered: survivorship topics, patient education or care resources and awareness education. 
Due Dates: Due Dates: Oct. 27 (OSR) Ι Oct. 31 (Sponsor)
Contact: Office of Sponsored Research (x6804)
Link: RFP
 

General Grants  

Research proposals may be individual projects or part of a larger project related to ovarian cancer. Proposals for clinical trials must be original investigational studies related to ovarian cancer in which the grantee is the primary investigator (PI) or co-PI.
Amount & Project Period: $50,000 -1 year
Eligibility: Established Investigators

Young Investigator (YI) Grants

Young investigator grants support career development in the area of ovarian cancer research.
Amount & Project Period: $50,000 -1 year
Eligibility: A post-doctoral fellow or asst. professor w/in 5 years (excluding clinical training) of completing terminal degree. OR
An assistant professor (or equiv.) w/in 3 years of initiating independent research.
Must have the support of a qualified mentor


NEW
November 01 (LOI) All Faculty Ranks Non-Federal Immunotherapies

Clinic Laboratory Integration Program (CLIP)

CLIP Grants provide funding for qualified scientists who are working to explore clinically relevant questions aimed at improving the effectiveness of cancer immunotherapies. The grant will support basic, pre-clinical, and translational research, which will provide information that can be directly applied to optimizing cancer immunotherapy in the clinic.
Due Dates: Nov. 01 (Letter of Intent)
Invited Applications:  Jan. 30 (OSR) Feb. 01, 2018 (Sponsor)
Amount & Project Period: $100,000/yr. - 2 years
Eligibility: Tenure Track Assistant Professor or higher (By award activation)
No citizenship restrictions
Contact: Office of Sponsored Research (x6804)
Link: CLIP Application Guidelines


NEW
November 01 All Ranks Non-Federal Career Development

American College of Surgeons
Faculty Research Fellowships

The purpose is to provide support to surgeons entering academic careers in surgery or a surgical specialty. The fellowship is to assist a surgeon in the establishment of their research program under mentorship with the goal of transitioning to becoming an independent investigator. Applicants should have demonstrated their potential to work as independent investigators.
Due Dates: Oct. 30 (OSR) Ι Nov. 01 (Sponsor)
Amount & Project Period: $80,000 - 2 years
Eligibility: Applicant must have:
(1) Completed chief residency year or accredited fellowship training w/in preceding 5 years, not including time off for maternity leave, military deployment, or medical leave; and (2) Received a full-time faculty appointment in a department of surgery or a surgical specialty.
Applicants who have previously won an award from another professional society or NIH are not eligible.
A minimum of 50% effort must be committed to research proposed in application, and may run concurrently with effort requirements of NIH or other accepted funding.
Contact: Office of Sponsored Research (x6804)
Link: ACS Faculty Research Fellowships


NEW
November 15 (LOI) All Faculty Ranks Non-Federal Immunotherapies

Technology Impact Grants

The grant aims to support development of highly innovative technologies that can ultimately be adopted by the research community at large and will enable researchers to develop the next generation cancer immunotherapies that can be effective and personalized for each patient. Technologies may facilitate understanding of the antigenic profile, cellular interplay, and mechanistic pathways within the tumor microenvironment that are essential for an effective anti-tumor response.
Due Dates: Nov. 15 (Letter of Intent)
Invited Applications:  Mar. 13 (OSR) Ι Mar. 15, 2018 (Sponsor)
Amount & Project Period: Up to $1,000,000 - 3  years
Eligibility: Tenure Track Assistant Professor or higher
Contact: Office of Sponsored Research (x6804)
Link: Overview | Impact Grants   
Toolbox
Funding Opportunities

Funding Opportunity Calendar
OSR's Grant News
grants.gov
NCI Funding Opportunities
NIH Guide to Grants & Contracts

RaceTracks

 Federal Opportunities
Moffitt-Sponsored (Intramural) Opportunities
Opportunities Focused on Thoracic Oncology		 Grant Preparation

Proposal Submission Form
Grants.gov Instructions
PHS398 Instructions
NIH 2590 Instructions

News

 NIH Research Matters
The Cancer Letter
NIH News & Events
Federal Register
Science 360 News
 Other

PubMed
National Cancer Institute

Clinical Research

Who To Call in Clinical Research
Clinical Research FAQs
Data Safety Monitoring Plan
Liberty IRB
USF IRB
Questions?
MRISignals@moffitt.org